Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07610590 · ClinicalTrials.gov registry record
guideSEQ: Genomic Understanding, Impact, Decision & Ethics in Prenatal Sequencing
A clinical trial, sponsored by Columbia University.
- Recruiting
- Registry status
- 1,042
- Enrollment target
NCT07610590 is a clinical trial that is actively recruiting participants, run by Columbia University. The registered enrollment target is 1,042 participants.
The verdict
NCT07610590 is actively recruiting participants, sponsored by Columbia University.
- RECRUITING
- Registry status
- 1,042 participants
- Enrollment target
Study Summary
This study looks at whether genome sequencing should be used more routinely during pregnancy, even when ultrasounds look normal. Genome sequencing can examine nearly all of a baby's genes and may find genetic conditions that standard tests do not detect. Researchers will compare this test with current prenatal testing to see if it provides helpful information for families and doctors. The study will also explore how parents decide what kinds of genetic information they want to receive and how this information affects their experience during pregnancy. The goal is to understand whether genome sequencing can be used in a way that is helpful, responsible, and supportive for families in the future.
Interventions
- GENETIC Genome Sequencing (GS)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,042 participants |
| Start Date | 2026-04-29 |
| Est. Completion | 2029-07-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07610590
The ClinicalTrials.gov registry entry for NCT07610590 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 1,042 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Columbia University, which has 958 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Genome Sequencing (GS) is the first listed.
NCT07610590 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07610590 about?
NCT07610590 is a clinical study titled "guideSEQ: Genomic Understanding, Impact, Decision & Ethics in Prenatal Sequencing". This study looks at whether genome sequencing should be used more routinely during pregnancy, even when ultrasounds look normal. Genome sequencing can examine nearly all of a baby's genes and may find genetic conditions that standard tests do not detect. Researchers will compare this test with curre...
What is the current status of trial NCT07610590?
This trial is currently recruiting. The enrollment target is 1,042 participants. The study started on 2026-04-29. Estimated completion is 2029-07-31.
What interventions are being tested in trial NCT07610590?
The interventions under investigation include: Genome Sequencing (GS) (GENETIC).
Who is sponsoring clinical trial NCT07610590?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.